1g5l

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1g5l.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1g5l.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1g5l| PDB=1g5l | SCENE= }}
{{STRUCTURE_1g5l| PDB=1g5l | SCENE= }}
-
'''CO(III)-BLEOMYCIN-OOH BOUND TO AN OLIGONUCLEOTIDE CONTAINING A PHOSPHOGLYCOLATE LESION'''
+
===CO(III)-BLEOMYCIN-OOH BOUND TO AN OLIGONUCLEOTIDE CONTAINING A PHOSPHOGLYCOLATE LESION===
-
==Overview==
+
<!--
-
Bleomycin (BLM) is an antitumor antibiotic that is used clinically. Its major cause of cytotoxicity is thought to be related to BLM's ability to cause double-strand (ds) DNA cleavage. A single molecule of BLM appears to cleave both strands of DNA in the presence of its required cofactors Fe(2+) and oxygen without dissociating from the helix. A mechanism for this process has been proposed based on a model structure of the hydroperoxide of Co(III)-BLM (CoBLM) bound sequence-specifically to an intact duplex containing a GTAC site, a hot spot for ds cleavage [Vanderwall, D. E., Lui, S. M., Wu, W., Turner, C. J., Kozarich, J. W., and Stubbe, J. (1997) Chem. Biol. 4, 373-387]. In this paper, we present a structural model for the second cleavage event. Two-dimensional NMR spectroscopy and molecular modeling were carried out to study CoBLM bound to d(CCAAAGXACTGGG).d(CCCAGTACTTTGG), where X represents a 3'-phosphoglycolate lesion next to a 5'-phosphate. Assignments of 729 NOEs, including 51 between the drug and the DNA and 126 within the BLM molecule, have been made. These NOEs in addition to 96 dihedral angle constraints have been used to obtain a well-defined structural model for this complex. The model reveals that the bithiazole tail is partially intercalated between the T19 and the A20 of the duplex and that the metal binding domain is poised for abstraction of the T19 H4' in the minor groove. The modeling further reveals that the predominant conformation of the bithiazole protons is trans. Two cis conformations of these protons are also observed, and ROESY experiments provide evidence for interconversion of all of these forms. The relationship of these observations to the model for ds cleavage is presented.
+
The line below this paragraph, {{ABSTRACT_PUBMED_11352724}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 11352724 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_11352724}}
==About this Structure==
==About this Structure==
-
Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1G5L OCA].
+
Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1G5L OCA].
==Reference==
==Reference==
Line 28: Line 32:
[[Category: Dna-drug complex]]
[[Category: Dna-drug complex]]
[[Category: Intercalation]]
[[Category: Intercalation]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 17:09:54 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 04:28:25 2008''

Revision as of 01:28, 1 July 2008

Template:STRUCTURE 1g5l

CO(III)-BLEOMYCIN-OOH BOUND TO AN OLIGONUCLEOTIDE CONTAINING A PHOSPHOGLYCOLATE LESION

Template:ABSTRACT PUBMED 11352724

About this Structure

Full experimental information is available from OCA.

Reference

Solution structure of Co(III)-bleomycin-OOH bound to a phosphoglycolate lesion containing oligonucleotide: implications for bleomycin-induced double-strand DNA cleavage., Hoehn ST, Junker HD, Bunt RC, Turner CJ, Stubbe J, Biochemistry. 2001 May 22;40(20):5894-905. PMID:11352724

Page seeded by OCA on Tue Jul 1 04:28:25 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools